Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 620

1.

Do Community Structural Characteristics Moderate the Association Between Mental Health and the Frequency and Severity of Violent-Behavioral Outcomes in Community Respondents?

Shaffer CS, Douglas KS, Fuller EK, Blanchard AJE, Viljoen JL.

J Interpers Violence. 2019 Dec 2:886260519888204. doi: 10.1177/0886260519888204. [Epub ahead of print]

PMID:
31789077
2.

Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients.

Roelsgaard IK, Ikdahl E, Rollefstad S, Wibetoe G, Esbensen BA, Kitas GD, van Riel P, Gabriel S, Kvien TK, Douglas K, Wållberg-Jonsson S, Rantapää Dahlqvist S, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon CA, Pascual-Ramos V, Contreras-Yáñez I, Sfikakis PP, González-Gay MA, Crowson CS, Semb AG.

Rheumatology (Oxford). 2019 Nov 28. pii: kez557. doi: 10.1093/rheumatology/kez557. [Epub ahead of print]

PMID:
31782789
3.

Interpersonal and Social Rhythm Therapy for Patients With Major Depressive Disorder.

Crowe M, Inder M, Douglas K, Carlyle D, Wells H, Jordan J, Lacey C, Mulder R, Beaglehole B, Porter R.

Am J Psychother. 2019 Nov 22:appipsychotherapy20190024. doi: 10.1176/appi.psychotherapy.20190024. [Epub ahead of print]

PMID:
31752508
4.

Identifying hotspots of type 2 diabetes risk using general practice data and geospatial analysis: an approach to inform policy and practice.

Bagheri N, Konings P, Wangdi K, Parkinson A, Mazumdar S, Sturgiss E, Lal A, Douglas K, Glasgow N.

Aust J Prim Health. 2019 Nov 22. doi: 10.1071/PY19043. [Epub ahead of print]

PMID:
31751519
5.

The Scope Of Three-Dimensional Digital Visualization Systems In Vitreoretinal Surgery.

Agranat JS, Miller JB, Douglas VP, Douglas KA, Marmalidou A, Cunningham MA, Houston SK 3rd.

Clin Ophthalmol. 2019 Oct 24;13:2093-2096. doi: 10.2147/OPTH.S213834. eCollection 2019.

6.

Improvement in cognitive function in young people with bipolar disorder: Results from participants in an 18-month randomised controlled trial of adjunctive psychotherapy.

Porter RJ, Inder M, Douglas KM, Moor S, Carter JD, Frampton CM, Crowe M.

Aust N Z J Psychiatry. 2019 Nov 16:4867419887794. doi: 10.1177/0004867419887794. [Epub ahead of print]

PMID:
31735057
7.

GPs at the Deep End: Identifying and addressing social disadvantage wherever it lies.

Sturgiss E, Tait PW, Douglas K, Chew JI, Baglow S, Watt G.

Aust J Gen Pract. 2019 Nov;48(11):811-813. doi: 10.31128/AJGP-06-19-4960.

8.

Relapsing Optic Neuropathy and Multiple Cranial Neuropathies in a Middle-Aged Woman.

Douglas KAA, Douglas VP, Cestari DM.

JAMA Ophthalmol. 2019 Nov 7. doi: 10.1001/jamaophthalmol.2019.4410. [Epub ahead of print] No abstract available.

PMID:
31697332
9.

Violence after discharge from forensic units in the safe pilot study: a prospective study with matched pair design.

Bjørkly S, Wærstad JM, Selmer LE, Wærp J, Bjørnstad M, Leinslie JV, Eidhammer G, Douglas KS.

Psychol Res Behav Manag. 2019 Aug 28;12:755-766. doi: 10.2147/PRBM.S214270. eCollection 2019.

10.

Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis.

Walsh JA, Pei S, Penmetsa GK, Sauer BC, Patil V, Walker JH, Clewell J, Douglas KM, Clegg DO, Cannon GW, Halwani A.

J Manag Care Spec Pharm. 2019 Nov;25(11):1218-1228. doi: 10.18553/jmcp.2019.25.11.1218.

11.

Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study.

Mease PJ, Liu C, Siegel E, Richmond H, Wu M, Chen L, Douglas K, Lockshin B.

Am J Clin Dermatol. 2019 Dec;20(6):873-880. doi: 10.1007/s40257-019-00470-6.

12.

Fulminant Pseudotumor Cerebri Syndrome Secondary to Over-the-Counter Topical Retinoids.

Douglas KAA, Douglas VP, Chwalisz BK.

J Neuroophthalmol. 2019 Oct 11. doi: 10.1097/WNO.0000000000000857. [Epub ahead of print] No abstract available.

PMID:
31609833
13.

Experimental Study of the Removal of Ground- and Excited-State Phosphorus Atoms by Atmospherically Relevant Species.

Douglas KM, Blitz MA, Mangan TP, Plane JMC.

J Phys Chem A. 2019 Nov 7;123(44):9469-9478. doi: 10.1021/acs.jpca.9b07855. Epub 2019 Oct 25.

PMID:
31603680
14.

Cognitive enhancement therapy for mood disorders: A new paradigm?

Douglas KM, Peckham A, Porter R, Hammar A.

Aust N Z J Psychiatry. 2019 Dec;53(12):1148-1150. doi: 10.1177/0004867419873711. Epub 2019 Sep 13. No abstract available.

PMID:
31516027
15.

Head and neck cancer survivors' preferences for and evaluations of a post-treatment dietary intervention.

Crowder SL, Douglas KG, Frugé AD, Carroll WR, Spencer SA, Locher JL, Demark-Wahnefried W, Rogers LQ, Arthur AE.

Nutr J. 2019 Sep 10;18(1):57. doi: 10.1186/s12937-019-0479-6.

16.

Serum LPS Associated with Hantavirus and Dengue Disease Severity in Barbados.

Douglas KO, Samuels TA, Gittens-St Hilaire M.

Viruses. 2019 Sep 9;11(9). pii: E838. doi: 10.3390/v11090838.

17.

Neuro-ophthalmic manifestations of the phakomatoses.

Douglas KAA, Douglas VP, Cestari DM.

Curr Opin Ophthalmol. 2019 Nov;30(6):434-442. doi: 10.1097/ICU.0000000000000609.

PMID:
31464700
18.

Immune checkpoint inhibitors: what neuro-ophthalmologists need to know.

Douglas VP, Douglas KAA, Cestari DM.

Curr Opin Ophthalmol. 2019 Nov;30(6):426-433. doi: 10.1097/ICU.0000000000000608.

PMID:
31449088
19.

Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study.

Isaacs JD, Salih A, Sheeran T, Patel YI, Douglas K, McKay ND, Naisbett-Groet B, Choy E.

Rheumatol Adv Pract. 2019 Apr 19;3(1):rkz010. doi: 10.1093/rap/rkz010. eCollection 2019.

20.

Cognitive impairment in people remitted from major depression.

Porter RJ, Douglas KM.

Lancet Psychiatry. 2019 Oct;6(10):799-800. doi: 10.1016/S2215-0366(19)30278-0. Epub 2019 Aug 15. No abstract available.

PMID:
31422921
21.

Interactions of High School Students With Intellectual and Developmental Disabilities in Inclusive Classrooms.

Chung YC, Douglas KH, Walker VL, Wells RL.

Intellect Dev Disabil. 2019 Aug;57(4):307-322. doi: 10.1352/1934-9556-57.4.307.

PMID:
31373547
22.

Case report: Orbital myositis triggering oxygen-responsive cluster headache.

Douglas VP, Douglas KAA, Rizzo JF 3rd, Chwalisz BK.

Cephalalgia. 2019 Jul 25:333102419865974. doi: 10.1177/0333102419865974. [Epub ahead of print]

PMID:
31345050
23.

New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review.

Rosenbaum JT, Bodaghi B, Couto C, Zierhut M, Acharya N, Pavesio C, Tay-Kearney ML, Neri P, Douglas K, Pathai S, Song AP, Kron M, Foster CS.

Semin Arthritis Rheum. 2019 Dec;49(3):438-445. doi: 10.1016/j.semarthrit.2019.06.004. Epub 2019 Jun 10. Review.

24.

Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences.

Zhou M, Desborough J, Parkinson A, Douglas K, McDonald D, Boom K.

Int J Pharm Pract. 2019 Dec;27(6):479-489. doi: 10.1111/ijpp.12557. Epub 2019 Jul 9. Review.

PMID:
31287208
25.

Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies.

Farr OM, Upadhyay J, Rutagengwa C, DiPrisco B, Ranta Z, Adra A, Bapatla N, Douglas VP, Douglas KAA, Nolen-Doerr E, Mathew H, Mantzoros CS.

Diabetes Obes Metab. 2019 Nov;21(11):2459-2464. doi: 10.1111/dom.13827. Epub 2019 Aug 8.

PMID:
31282006
26.

Traumatic imagery following glucocorticoid administration in earthquake-related post-traumatic stress disorder: A preliminary functional magnetic resonance imaging study.

Douglas KM, Groves S, Porter RJ, Jordan J, Wilson L, Melzer TR, Wise RG, Bisson JI, Bell CJ.

Aust N Z J Psychiatry. 2019 Dec;53(12):1167-1178. doi: 10.1177/0004867419851860. Epub 2019 May 31.

PMID:
31146540
27.

Sexual assault and harassment of doctors, by doctors: a qualitative study.

Stone L, Phillips C, Douglas KA.

Med Educ. 2019 Aug;53(8):833-843. doi: 10.1111/medu.13912. Epub 2019 May 29.

PMID:
31144346
28.

Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian Cancer.

Feldmann DP, Jones S, Douglas K, Shields AF, Merkel OM.

Methods Mol Biol. 2019;1974:355-369. doi: 10.1007/978-1-4939-9220-1_24.

29.

Effectiveness of and Dental Student Satisfaction with Three Teaching Methods for Behavior Guidance Techniques in Pediatric Dentistry.

Slaven CM, Wells MH, DeSchepper EJ, Dormois L, Vinall CV, Douglas K.

J Dent Educ. 2019 Aug;83(8):966-972. doi: 10.21815/JDE.019.091. Epub 2019 May 13.

PMID:
31085686
30.

Carbohydrate Nutrition and the Risk of Cancer.

Maino Vieytes CA, Taha HM, Burton-Obanla AA, Douglas KG, Arthur AE.

Curr Nutr Rep. 2019 Sep;8(3):230-239. doi: 10.1007/s13668-019-0264-3. Review.

31.

Primary care in disasters: opportunity to address a hidden burden of health care.

Burns PL, Douglas KA, Hu W.

Med J Aust. 2019 Apr;210(7):297-299.e1. doi: 10.5694/mja2.50067. Epub 2019 Mar 19. No abstract available.

PMID:
30888072
32.

Exposure to intergroup conspiracy theories promotes prejudice which spreads across groups.

Jolley D, Meleady R, Douglas KM.

Br J Psychol. 2019 Mar 13. doi: 10.1111/bjop.12385. [Epub ahead of print]

PMID:
30868563
33.

Examining the triarchic psychopathy measure and comprehensive assessment of psychopathic personality in self-identified offender populations.

Hanniball KB, Gatner DT, Douglas KS, Viljoen JL, Aknin LB.

Personal Disord. 2019 Jul;10(4):340-353. doi: 10.1037/per0000333. Epub 2019 Feb 28.

PMID:
30816778
34.

Examining teachers' ratings of feedback following success and failure: a study of Chinese English teachers.

Skipper Y, Douglas KM.

Br J Educ Psychol. 2019 Dec;89(4):804-817. doi: 10.1111/bjep.12261. Epub 2019 Feb 8.

PMID:
30734921
35.

Activation therapy for the treatment of inpatients with depression - protocol for a randomised control trial compared to treatment as usual.

Averill IRE, Beaglehole B, Douglas KM, Jordan J, Crowe MT, Inder M, Lacey CJ, Frampton CM, Bowie CR, Porter RJ.

BMC Psychiatry. 2019 Feb 1;19(1):52. doi: 10.1186/s12888-019-2038-2.

36.

Feasibility Outcomes of a Pilot Randomized Clinical Trial to Increase Cruciferous and Green Leafy Vegetable Intake in Posttreatment Head and Neck Cancer Survivors.

Crowder SL, Frugé AD, Douglas KG, Chen YT, Moody L, Delk-Licata A, Erdman JW Jr, Black M, Carroll WR, Spencer SA, Locher JL, Demark-Wahnefried W, Rogers LQ, Arthur AE.

J Acad Nutr Diet. 2019 Apr;119(4):659-671. doi: 10.1016/j.jand.2018.11.005. Epub 2019 Jan 17.

PMID:
30661935
37.

Belief in conspiracy theories and intentions to engage in everyday crime.

Jolley D, Douglas KM, Leite AC, Schrader T.

Br J Soc Psychol. 2019 Jul;58(3):534-549. doi: 10.1111/bjso.12311. Epub 2019 Jan 19.

PMID:
30659628
38.

Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927.

Kahraman M, Govek SP, Nagasawa JY, Lai A, Bonnefous C, Douglas K, Sensintaffar J, Liu N, Lee K, Aparicio A, Kaufman J, Qian J, Shao G, Prudente R, Joseph JD, Darimont B, Brigham D, Heyman R, Rix PJ, Hager JH, Smith ND.

ACS Med Chem Lett. 2018 Dec 6;10(1):50-55. doi: 10.1021/acsmedchemlett.8b00414. eCollection 2019 Jan 10.

PMID:
30655946
39.

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.

Joseph JD, Darimont B, Zhou W, Arrazate A, Young A, Ingalla E, Walter K, Blake RA, Nonomiya J, Guan Z, Kategaya L, Govek SP, Lai AG, Kahraman M, Brigham D, Sensintaffar J, Lu N, Shao G, Qian J, Grillot K, Moon M, Prudente R, Bischoff E, Lee KJ, Bonnefous C, Douglas KL, Julien JD, Nagasawa JY, Aparicio A, Kaufman J, Haley B, Giltnane JM, Wertz IE, Lackner MR, Nannini MA, Sampath D, Schwarz L, Manning HC, Tantawy MN, Arteaga CL, Heyman RA, Rix PJ, Friedman L, Smith ND, Metcalfe C, Hager JH.

Elife. 2019 Jan 7;8. pii: e44851. doi: 10.7554/eLife.44851.

40.

Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft.

Govek SP, Bonnefous C, Julien JD, Nagasawa JY, Kahraman M, Lai AG, Douglas KL, Aparicio AM, Darimont BD, Grillot KL, Joseph JD, Kaufman JA, Lee KJ, Lu N, Moon MJ, Prudente RY, Sensintaffar J, Rix PJ, Hager JH, Smith ND.

Bioorg Med Chem Lett. 2019 Feb 1;29(3):367-372. doi: 10.1016/j.bmcl.2018.12.042. Epub 2018 Dec 19.

PMID:
30587451
41.

Belief in conspiracy theories: Basic principles of an emerging research domain.

van Prooijen JW, Douglas KM.

Eur J Soc Psychol. 2018 Dec;48(7):897-908. doi: 10.1002/ejsp.2530. Epub 2018 Aug 24.

42.

Adaption and validation of the Working Alliance Inventory for General Practice: qualitative review and cross-sectional surveys.

Sturgiss EA, Rieger E, Haesler E, Ridd MJ, Douglas K, Galvin SL.

Fam Pract. 2019 Jul 31;36(4):516-522. doi: 10.1093/fampra/cmy113.

43.

Flattering to deceive: Why people misunderstand benevolent sexism.

Hopkins-Doyle A, Sutton RM, Douglas KM, Calogero RM.

J Pers Soc Psychol. 2019 Feb;116(2):167-192. doi: 10.1037/pspa0000135. Epub 2018 Oct 25.

PMID:
30359066
44.

The Role of Life Satisfaction in Predicting Youth Violence and Offending: A Prospective Examination.

Hanniball KB, Viljoen JL, Shaffer CS, Bhatt G, Tweed R, Aknin LB, Gagnon N, Douglas KS, Dooley S.

J Interpers Violence. 2018 Oct 13:886260518805103. doi: 10.1177/0886260518805103. [Epub ahead of print]

PMID:
30317908
45.

Wulff in a cage gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging.

Hajfathalian M, Amirshaghaghi A, Naha PC, Chhour P, Hsu JC, Douglas K, Dong Y, Sehgal CM, Tsourkas A, Neretina S, Cormode DP.

Nanoscale. 2018 Oct 21;10(39):18749-18757. doi: 10.1039/c8nr05203d. Epub 2018 Oct 2.

46.

The influence of therapeutic alliance on adult obesity interventions in primary care: A systematic review protocol.

Sturgiss E, Elmitt N, Agostino J, Douglas K, Clark AM.

Aust J Gen Pract. 2018 Sep;47(9):646-649. doi: 10.31128/AJGP-03-18-4538.

PMID:
30244563
47.

Quantifying Platelet Margination in Diabetic Blood Flow.

Chang HY, Yazdani A, Li X, Douglas KAA, Mantzoros CS, Karniadakis GE.

Biophys J. 2018 Oct 2;115(7):1371-1382. doi: 10.1016/j.bpj.2018.08.031. Epub 2018 Aug 30.

48.

A Systematic Review of Cognitive Predictors of Treatment Outcome in Major Depression.

Groves SJ, Douglas KM, Porter RJ.

Front Psychiatry. 2018 Aug 28;9:382. doi: 10.3389/fpsyt.2018.00382. eCollection 2018.

49.

Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer.

Nagasawa J, Govek S, Kahraman M, Lai A, Bonnefous C, Douglas K, Sensintaffar J, Lu N, Lee K, Aparicio A, Kaufman J, Qian J, Shao G, Prudente R, Joseph JD, Darimont B, Brigham D, Maheu K, Heyman R, Rix PJ, Hager JH, Smith ND.

J Med Chem. 2018 Sep 13;61(17):7917-7928. doi: 10.1021/acs.jmedchem.8b00921. Epub 2018 Sep 4.

PMID:
30086626
50.

Metabolic syndrome and weight management programs in primary care: a comparison of three international healthcare systems.

Sturgiss E, Madigan CD, Klein D, Elmitt N, Douglas K.

Aust J Prim Health. 2018 Nov;24(5):372-377. doi: 10.1071/PY18021.

PMID:
30056826

Supplemental Content

Loading ...
Support Center